HMGB2 and esophageal squamous cell carcinoma: In an in vitro co-culture assay, we further confirmed that HMGB2-deficient NK cells showed enhanced killing ability on a variety of ESCC cell lines, especially in poorly differentiated tumor cells such as KYSE70 and KYSE150.